Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival.

Authors :: Lokhorst HM
van der Holt B
Cornelissen JJ
Kersten MJ
van Oers M
Raymakers R
Minnema MC
Zweegman S
Bos G
Schaap N
Wittebol S
de Weerdt O
Ammerlaan R
Sonneveld P
Source :: Haematologica [Haematologica] 2015 Dec; Vol. 100 (12), pp. e508-10. Date of Electronic Publication: 2015 Sep 04.
Publication Year :: 2015

Subjects :: Allografts
Autografts
Disease-Free Survival
Female
Humans
Male
Survival Rate
Multiple Myeloma mortality
Multiple Myeloma therapy
Stem Cell Transplantation

Full Text Access

Tools